BioCentury | Jan 4, 2021
Deals

Angelini adds registrational epilepsy program via $610M Arvelle takeout

...sell its 12% stake to Angelini and remains eligible for milestones. Other investors in Arvelle include NovaQuest...
BioCentury | May 28, 2020
Finance

May 27 Quick Takes: Atara raises $176M on back of MS data; plus Exscientia’s $60M C round, Geron, Silence, Arvelle, ViaCyte, Poxel, Accure, Tollys

...the final $42.7 million tranche of Arvelle Therapeutics GmbH’s $133.3 million series A. Investors included NovaQuest...
BioCentury | Nov 11, 2019
Emerging Company Profile

Mycovia tackling chronic infections with antifungal pipeline

...been left behind,” said CEO Patrick Jordan, who is also a partner at Mycovia investor NovaQuest...
...could have worldwide sales of up to $700 million. VT-1161 originated at Viamet Pharmaceuticals Inc. NovaQuest...
...Inc. with Jordan at the helm. While Mycovia is still majority owned and funded by NovaQuest...
BioCentury | Feb 16, 2019
Company News

Emerging company roundup: Passage, IFM, Grey Wolf, Culture

...Therapeutics GmbH (Basel, Switzerland). The newco raised more than $100 million from a syndicate including NovaQuest...
BioCentury | Feb 15, 2019
Company News

Axovant spins out small molecule team to form CNS-focused newco

...Korea). Arvelle is raising the money in a series A round from a syndicate including NovaQuest...
BioCentury | Feb 14, 2019
Company News

Axovant spins out small molecule team to form CNS-focused newco

...Korea). Arvelle is raising the money in a series A round from a syndicate including NovaQuest...
BioCentury | Nov 16, 2018
Financial News

Roivant, now valued at $7B, raises $200M in equity financing

...on Nov. 13, which Roivant says values the company at about $7 billion. New investors NovaQuest...
BioCentury | Nov 13, 2018
Financial News

Roivant, now valued at $7B, raises $200M in equity financing

...fourth equity financing, which Roivant says values the company at about $7 billion. New investors NovaQuest...
BioCentury | Aug 31, 2018
Company News

Dermavant, NovaQuest in milestone deal for tapinarof

...Sciences dermatology subsidiary of Roivant Sciences GmbH (Basel, Switzerland) received the $100 million investment from NovaQuest...
...NovaQuest Capital Management LLC, Raleigh, N.C. Business: Dermatology Alicia Parker GSK2894512, WBI-1001, tapinarof Roivant Sciences GmbH Aryl hydrocarbon receptor (AHR) NovaQuest...
BioCentury | Aug 28, 2018
Company News

Roivant units Urovant, Dermavant in deals as NEA’s Torti joins ‘vant’ team

...forming subunit of the large conductance potassium channel. Dermavant received the $100 million investment from NovaQuest...
Items per page:
1 - 10 of 56
BioCentury | Jan 4, 2021
Deals

Angelini adds registrational epilepsy program via $610M Arvelle takeout

...sell its 12% stake to Angelini and remains eligible for milestones. Other investors in Arvelle include NovaQuest...
BioCentury | May 28, 2020
Finance

May 27 Quick Takes: Atara raises $176M on back of MS data; plus Exscientia’s $60M C round, Geron, Silence, Arvelle, ViaCyte, Poxel, Accure, Tollys

...the final $42.7 million tranche of Arvelle Therapeutics GmbH’s $133.3 million series A. Investors included NovaQuest...
BioCentury | Nov 11, 2019
Emerging Company Profile

Mycovia tackling chronic infections with antifungal pipeline

...been left behind,” said CEO Patrick Jordan, who is also a partner at Mycovia investor NovaQuest...
...could have worldwide sales of up to $700 million. VT-1161 originated at Viamet Pharmaceuticals Inc. NovaQuest...
...Inc. with Jordan at the helm. While Mycovia is still majority owned and funded by NovaQuest...
BioCentury | Feb 16, 2019
Company News

Emerging company roundup: Passage, IFM, Grey Wolf, Culture

...Therapeutics GmbH (Basel, Switzerland). The newco raised more than $100 million from a syndicate including NovaQuest...
BioCentury | Feb 15, 2019
Company News

Axovant spins out small molecule team to form CNS-focused newco

...Korea). Arvelle is raising the money in a series A round from a syndicate including NovaQuest...
BioCentury | Feb 14, 2019
Company News

Axovant spins out small molecule team to form CNS-focused newco

...Korea). Arvelle is raising the money in a series A round from a syndicate including NovaQuest...
BioCentury | Nov 16, 2018
Financial News

Roivant, now valued at $7B, raises $200M in equity financing

...on Nov. 13, which Roivant says values the company at about $7 billion. New investors NovaQuest...
BioCentury | Nov 13, 2018
Financial News

Roivant, now valued at $7B, raises $200M in equity financing

...fourth equity financing, which Roivant says values the company at about $7 billion. New investors NovaQuest...
BioCentury | Aug 31, 2018
Company News

Dermavant, NovaQuest in milestone deal for tapinarof

...Sciences dermatology subsidiary of Roivant Sciences GmbH (Basel, Switzerland) received the $100 million investment from NovaQuest...
...NovaQuest Capital Management LLC, Raleigh, N.C. Business: Dermatology Alicia Parker GSK2894512, WBI-1001, tapinarof Roivant Sciences GmbH Aryl hydrocarbon receptor (AHR) NovaQuest...
BioCentury | Aug 28, 2018
Company News

Roivant units Urovant, Dermavant in deals as NEA’s Torti joins ‘vant’ team

...forming subunit of the large conductance potassium channel. Dermavant received the $100 million investment from NovaQuest...
Items per page:
1 - 10 of 56